Search

everythinglearnresearchcommunity

for

Search:↓

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

The drug combination was safe and showed promise in treating advanced tumors.

Axitinib treatment turned a man's grey hair back to black.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Blocking mTORC1 reduces skin tumor growth in mice.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib taken by mouth helps treat hair loss in children.

A man treated with gefitinib for lung cancer grew new hair on his bald scalp.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Tofacitinib may help treat hair loss in children with alopecia areata.